Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concentra Group Holdings Parent (CON) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for Concentra Group Holdings Parent (CON) over the last 3 years, with Q3 2025 value amounting to $49.9 million.

  • Concentra Group Holdings Parent's Cash & Equivalents fell 6349.93% to $49.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.9 million, marking a year-over-year decrease of 6349.93%. This contributed to the annual value of $183.3 million for FY2024, which is 48409.83% up from last year.
  • Per Concentra Group Holdings Parent's latest filing, its Cash & Equivalents stood at $49.9 million for Q3 2025, which was down 6349.93% from $73.9 million recorded in Q2 2025.
  • Concentra Group Holdings Parent's Cash & Equivalents' 5-year high stood at $183.3 million during Q4 2024, with a 5-year trough of $31.4 million in Q4 2023.
  • Its 3-year average for Cash & Equivalents is $82.6 million, with a median of $52.1 million in 2025.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 48409.83% in 2024, then plummeted by 6349.93% in 2025.
  • Quarter analysis of 3 years shows Concentra Group Holdings Parent's Cash & Equivalents stood at $31.4 million in 2023, then surged by 484.1% to $183.3 million in 2024, then tumbled by 72.75% to $49.9 million in 2025.
  • Its Cash & Equivalents was $49.9 million in Q3 2025, compared to $73.9 million in Q2 2025 and $52.1 million in Q1 2025.